Prevention and management of bortezomib-induced peripheral neuropathy in patients with multiple myelomaС. В. Семочкин, Л. П. Менделеева, M. V. Solovyev|Oncohematology|2022Cited by 6
Multiple myeloma: Maintenance therapy after autologous hematopoietic stem cell transplantation, depending on minimal residual diseaseM. V. Solovyev, Savchenko Vg, Э Г Гемджян et al.|Terapevticheskii arkhiv|2017Cited by 4
Prognostic value of 1q21 amplification in multiple myelomaTatiana Abramova, Savchenko Vg, Т. Н. Обухова et al.|Terapevticheskii arkhiv|2017Cited by 4
Uromodulin gene polymorphisms in patients with cast nephropathy in multiple myelomaИ Г Рехтина, Andrey Sudarikov, Л. П. Менделеева et al.|Terapevticheskii arkhiv|2017Cited by 2
Early and late relapses of multiple myeloma after autologous haematopoietic stem cell transplantationE. A. Mamaeva, Larisa A. Kuzmina, Л. П. Менделеева et al.|Гематология и трансфузиология|2021Cited by 0